BOSTON & LAUSANNE, Switzerland--(BUSINESS WIRE)--SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, was honored to accept the ...
Jessie Beebe, Senior Research Associate at Colossal Biosciences, is at the forefront of innovative research at the intersection of biotechnology, genetics, and conservation science. Based in Dallas, ...
Krystal Biotech is strategically positioned in the biotech sector with its unique focus on developing genetic medicines for rare diseases, offering a promising investment opportunity. Krystal ...
Morning Overview on MSN
POSTECH platform uses non-genetic DNA to control cells without rewriting genes
Researchers at Pohang University of Science and Technology (POSTECH) have built a platform that steers cell behavior using ...
MIAMI, May 15, 2024 /PRNewswire/ -- 4Cable TV International, Inc. (CATV) soon to be known as Category V Biotech, Inc. (OTC: CATV) announced today the execution of a ...
AMSTERDAM--(BUSINESS WIRE)--Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe diseases, today announced that it has entered into a Cooperative ...
Genetic engineering, also known as genetic modification, is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to ...
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Shares of UniQure, the Netherlands-based gene therapy ...
Transcription and translation are processes a cell uses to make all proteins the body needs to function from information stored in the sequence of bases in DNA. The four bases (C, A, T/U, and G in the ...
PLOS Biology, a peer-reviewed open-access journal, recently asked “eight leaders” for their predictions about the next ten years in genetics and genomics. Many responses acknowledge that this task may ...
23andMe is scaling up its pipeline with the help of its collaborators. Fulgent Genetics is rapidly building its oncology testing business. 23andMe's strategy will take longer to pay off, but it could ...
Morning Overview on MSN
New platform uses non-genetic DNA to control cells without altering genes
Researchers have built a platform that programs short DNA fragments inside living cells to control protein activity, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results